could glp-1 be the next mental health drug GLP-1s may improve some outcomes in addition to lowering body weight Now, new research suggests that

You take it orally, and the timing matters

Wegovy (Semaglutid): Gewichtsmanagement

16 Using the Danish nationwide registries, the purpose of this paper was to (1) compare the 1year risk of addon glucoselowering therapy and nonadherence among patients with prediabetes (HbA1c 4247 mmol/mol) or diabetes (HbA1c 48 mmol/mol) in firstline treatment with GLP1 RA or metformin

If additional glycemic control is needed, the dose can be increased by 2.5 mg every 4 weeks, and the maximum dose of this drug is 15 mg once a week

The peptide structure requires specialized handling techniques and storage conditions to maintain therapeutic activity throughout the product lifecycle

The mechanisms observed in controlled laboratory settings may not fully translate to real-world clinical outcomes, and the durability of any effect remains uncertain